230 related articles for article (PubMed ID: 16735937)
21. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.
Power ML; Schulkin J; Rossouw JE
Menopause; 2007; 14(1):20-8. PubMed ID: 17019376
[TBL] [Abstract][Full Text] [Related]
22. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(2):168-82. PubMed ID: 17259911
[TBL] [Abstract][Full Text] [Related]
23. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
[TBL] [Abstract][Full Text] [Related]
24. EMAS position statement: Managing menopausal women with a personal or family history of VTE.
Tremollieres F; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Vujovic S; Rozenberg S; Rees M;
Maturitas; 2011 Jun; 69(2):195-8. PubMed ID: 21489728
[TBL] [Abstract][Full Text] [Related]
25. Current trends in hormone replacement therapy: perceptions and usage.
Birkhäuser MH; Reinecke I
Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
[TBL] [Abstract][Full Text] [Related]
26. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trial.
Lekander I; Borgström F; Ström O; Zethraeus N; Kanis JA
Bone; 2008 Feb; 42(2):294-306. PubMed ID: 18053789
[TBL] [Abstract][Full Text] [Related]
27. Is there a place for postmenopausal hormone therapy use in women with lupus?
Gompel A; Piette JC
Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
[TBL] [Abstract][Full Text] [Related]
28. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy: time to move on?
Davey DA
J Br Menopause Soc; 2006 Jun; 12(2):75-80. PubMed ID: 16776859
[TBL] [Abstract][Full Text] [Related]
30. Provider management of menopause after the findings of the Women's Health Initiative.
Rolnick SJ; Jackson J; Kopher R; Defor TA
Menopause; 2007; 14(3 Pt 1):441-9. PubMed ID: 17318028
[TBL] [Abstract][Full Text] [Related]
31. The pitfalls of non-evidence-based guidelines.
Col NF; Duffy C; Cyr MG
Menopause; 2006; 13(3):334-7. PubMed ID: 16735929
[No Abstract] [Full Text] [Related]
32. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
Ettinger B
Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
[TBL] [Abstract][Full Text] [Related]
33. Oral contraceptives, hormone therapy and cardiovascular risk.
Shapiro S
Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
[TBL] [Abstract][Full Text] [Related]
34. Postmenopausal hormone therapy and risk of breast cancer.
Chen FP
Chang Gung Med J; 2009; 32(2):140-7. PubMed ID: 19403003
[TBL] [Abstract][Full Text] [Related]
35. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
Power ML; Zinberg S; Schulkin J
Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
[TBL] [Abstract][Full Text] [Related]
36. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
37. [The general practitioner's view on hormone replacement therapy during and after menopause].
Gjelsvik B; Swensen E; Hjortdahl P
Tidsskr Nor Laegeforen; 2007 May; 127(11):1500-3. PubMed ID: 17551553
[TBL] [Abstract][Full Text] [Related]
38. Current status of hormone therapy and breast cancer.
Norman RJ; MacLennan AH
Hum Reprod Update; 2005; 11(6):541-3. PubMed ID: 16150811
[TBL] [Abstract][Full Text] [Related]
39. Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
Skouby SO; Barlow D; Samsioe G; Gompel A; Pines A; Al-Azzawi F; Graziottin A; Hudita D; Rozenberg S;
Maturitas; 2004 May; 48(1):19-25. PubMed ID: 15223104
[TBL] [Abstract][Full Text] [Related]
40. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy.
Løkkegaard E; Jovanovic Z; Heitmann BL; Keiding N; Ottesen B; Pedersen AT
Maturitas; 2006 Jan; 53(2):226-33. PubMed ID: 15955642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
